GSK1360707F is a potent and selective triple reuptake inhibitor.

[1] It is chemically related to amitifadine and NS-2359 (GSK-372,475).

Until recently,[when?]

it was under development for the treatment of major depressive disorder; its development was put on hold for strategic reasons.

[citation needed] GSK1360707F has recently (2013) been tested on baboons (Papio anubis) & humans for transporter occupancy using PET.